Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

BACKGROUND: Intravesical chemotherapy and bacillus Calmette-Guérin (BCG) reduce the recurrence rate in patients with stage Ta T1 urothelial bladder cancer; however, the benefit of BCG relative to chemotherapy for long-term end points is controversial, especially in intermediate-risk patients. OBJECT...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sylvester, Richard J., Brausi, Maurizio A., Kirkels, Wim J., Hoeltl, Wolfgang, Da Silva, Fernando Calais, Powell, Philip H., Prescott, Stephen, Kirkali, Ziya, van de Beek, Cees, Gorlia, Thierry, de Reijke, Theo M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889174/
https://ncbi.nlm.nih.gov/pubmed/20034729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2009.12.024
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares